Expertise in
13
conditions

Changsheng Y. Ma

Key Laboratory Of Major Diseases In Children, Ministry Of Education, 
Beijing, CN 
Expertise in
13
conditions
Key Laboratory Of Major Diseases In Children, Ministry Of Education, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Changsheng Ma practices in Beijing, China. Ma is highly rated in 13 conditions, according to our data. Their top areas of expertise are Atrial Fibrillation, Acute Coronary Syndrome, Heart Attack, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).

Their clinical research consists of co-authoring 254 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Key Laboratory Of Major Diseases In Children, Ministry Of Education, Beijing, 100045, China
Other Locations
Suzhou, 215006, China
Wuxi, 214062, China
Longxian Chengguanzhen, China
No. 30, Dongyuan Road, Futian District, Shenzhen, 518000, China
Shijiazhang, China
Nantong, 226300, China
Changzhou, China
Department Of Oral Maxillofacial Head Neck Oncology, Shanghai Key Laboratory Of Stomatology, Shanghai, China
Zhanjiang, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Prospective Randomized Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation
Prospective Randomized Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation
Enrollment Status: Completed
Publish Date: July 19, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Multi-center, Randomized, Double-blind, Double-Dummy, Positive Parallel Controlled Study to Evaluate the Efficacy and Safety in Treatment of Mild-moderate Essential Hypertension
A Multi-center, Randomized, Double-blind, Double-Dummy, Positive Parallel Controlled Study to Evaluate the Efficacy and Safety in Treatment of Mild-moderate Essential Hypertension
Enrollment Status: Completed
Publish Date: May 07, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Multicentre, Randomized, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in the Stable Treatment of Patients With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia .
A Multicentre, Randomized, Double-blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in the Stable Treatment of Patients With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia .
Enrollment Status: Completed
Publish Date: January 31, 2024
Intervention Type: Drug
Study Drug: SHR-1209
Study Phase: Phase 3
To Evaluate the Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients: A Randomized, Double-Blinded, Dose-Exploration and Placebo-Controlled Study
To Evaluate the Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients: A Randomized, Double-Blinded, Dose-Exploration and Placebo-Controlled Study
Enrollment Status: Completed
Publish Date: November 15, 2021
Intervention Type: Drug
Study Drug: SPH3127
Study Phase: Phase 2
View 4 Less Clinical Trials

254 Total Publications

Clinical evaluation of instantly generated inhaled nitric oxide in the treatment of neonatal pulmonary arterial hypertension
Clinical evaluation of instantly generated inhaled nitric oxide in the treatment of neonatal pulmonary arterial hypertension
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: October 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ma's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 39 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile